21247 Results

People

  1. Brennan
    Brennan
  2. Jarnagin
    Jarnagin
  3. Abu-Rustum
    Abu-Rustum
  4. Rusch
    Rusch
  5. D'Angelica
    D'Angelica
  6. Fong
    Fong
  7. Morrow
    Morrow
  8. Shah
    Shah
  9. Chi
    Chi
  10. Shaha
    Shaha

Groups

  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)
  7. Department of Pathology and Laboratory Medicine (3639)
  8. Center for Pancreatic Cancer Research (3115)
  9. Population Sciences Research Program (2966)
  10. GSK Faculty (2773)
  1. "Surgery"
Formats
  1. Journal Article (13274)
  2. Meeting Abstract (4871)
  3. Book Section (1145)
  4. Review (581)
  5. Editorial (559)
  6. Conference Paper (249)
  7. Correspondence (151)
  8. Miscellaneous (141)
  9. Guidelines (125)
  10. Book Whole (91)
  11. Research Letter (60)
Groups
  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)

More Groups

People
  1. Murray Brennan (1059)
  2. William Jarnagin (903)
  3. Nadeem Abu-Rustum (888)
  4. Valerie Rusch (864)
  5. Michael D'Angelica (777)
  6. Yuman Fong (775)

More People

Years
  1. 2025 (375)
  2. 2024 (984)
  3. 2023 (930)
  4. 2022 (1036)
  5. 2021 (954)
  6. 2020 (919)

More Years

Publications
  1. Journal of Clinical Oncology (1551)
  2. Annals of Surgical Oncology (1512)
  3. Gynecologic Oncology (874)
  4. Journal of Urology (548)
  5. International Journal of Radiation Oncology, Biology, Physics (458)
  6. Cancer (424)

More Publications

Publishers
  1. Elsevier Inc. (3546)
  2. Springer (2678)
  3. Elsevier Science, Inc. (2049)
  4. Lippincott Williams & Wilkins (1663)
  5. American Society of Clinical Oncology (1644)
  6. Wiley Blackwell (1224)

More Publishers

Results (21247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular and tumor microenvironmental characterization of HPV-negative invasive squamous cell carcinoma of the vulva
    Meeting Abstract

    Moufarrij, S.; Filippova, O.; Paula, A. D.; Heredia, J. B.; Leitao, M.; O'Cearbhaill, R.; Abu-Rustum, N.; Park, K.; Weigelt, B.; Zamarin, D.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Folate receptor positivity in low-grade serous ovarian cancer: Exploring new therapeutic possibilities
    Meeting Abstract

    Manning-Geist, B.; Sullivan, M.; Zhou, Q.; Iasonos, A.; Stallworth, C.; Liu, Y.; Roche, K. L.; Gordhandas, S.; Chi, D.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Concurrent POLE hotspot mutations and mismatch repair deficiency in endometrial cancer: Defining cancer drivers
    Meeting Abstract

    Moufarrij, S.; Gazzo, A.; Selenica, P.; Abu-Rustum, N.; Ellenson, L.; Liu, Y.; Weigelt, B.; Momeni-Boroujeni, A.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Sensitivity of HER2-low uterine carcinosarcoma organoids to the antibody-drug conjugate, trastuzumab deruxtecan
    Meeting Abstract

    Moufarrij, S.; Dopeso, H.; Green, H.; Gill, K.; Brown, D.; Zammarrelli, W.; Varice, N.; Wu, M.; Paula, A. D.; de Oliveira, T. B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Lymph node metastases in endometrial cancer: A modern assessment in the era of sentinel lymph node mapping and molecular classification
    Meeting Abstract

    Praiss, A.; Dagher, C.; Zhou, Q.; Iasonos, A.; Rios-Doria, E.; Abu-Rustum, N.; Weigelt, B.; Ellenson, L.; Leitao, M.; Mueller, J.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Molecular subtypes and genomic landscape of undifferentiated and dedifferentiated endometrial cancer
    Meeting Abstract

    Dagher, C.; Selenica, P.; Momeni-Boroujeni, A.; Mueller, J.; Abu-Rustum, N.; Chui, H.; Weigelt, B.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of efficacy and fertility after non-radical surgical therapy (extra fascial hysterectomy or cone biopsy with pelvic lymphadenectomy) for stage IA1 (LVSI+) and IA2-IB1 (GOG-278) cervical cancer
    Meeting Abstract

    Covens, A.; Huang, H.; Kim, Y. B.; Kim, M. H.; DiSilvestro, P.; Vicus, D.; Holman, L.; Fleury, A.; Pearson, J.; Thawani, N.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Mainstreaming in gynecologic oncology clinics triples the odds of genetic testing among patients with epithelial ovarian cancer
    Meeting Abstract

    Sia, T.; Byrne, M.; Fong, C.; Khurram, A.; Zhou, Q.; Saban, S.; Wu, M.; Varice, N.; Hamilton, J.; Carrot Zhang, J.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Progression-free and overall survival in newly-diagnosed homologous recombination DNA-repair deficient ovarian cancer without a BRCA mutation
    Meeting Abstract

    Graves, S.; Sullivan, M.; Adkoli, A.; Zhou, Q.; Chi, D.; Ellenson, L.; O'Cearbhaill, R.; Weigelt, B.; Grisham, R.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of physical function and quality of life before and after non-radical surgical therapy (extra fascial hysterectomy or cone biopsy with pelvic lymphadenectomy) for stage IA1 (LVSI+) and IA2-IB1 cervical cancer (GOG-278)
    Meeting Abstract

    Covensa, A.; Huang, H.; Kim, Y. B.; Kim, M. H.; Stuckey, A.; Vicus, D.; Holman, L.; Fleury, A.; Pearson, J.; Thawani, N.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save